Home Of Hope Helping Breast Cancer Patients During Difficult Time « CBS Pittsburgh : cbslocal

as mentioned in cbslocal

Home Of Hope Helping Breast Cancer Patients During Difficult Time « CBS Pittsburgh

Home Of Hope Helping Breast Cancer Patients During Difficult Time « CBS Pittsburgh

PITTSBURGH (KDKA) – A breast cancer diagnosis is devastating at any age, but for younger women, it's especially difficult – dealing with treatments and keeping up with normal, everyday stresses.A new program hopes to help those women carry some of that burden.Lissa Yanak, 27, was shocked by a devastating finding."My husband and I just moved to Pittsburgh in October," Yanak said.


in the same way wunc

Study Of Breast Cancer Treatment Reveals Paradox Of Precision Medicine

Study Of Breast Cancer Treatment Reveals Paradox Of Precision Medicine

A major study about the best way to treat early-stage breast cancer reveals that "precision medicine" doesn't provide unambiguous answers about how to choose the best therapy."Precision doesn't mean certainty," says David Hunter, a professor of cancer prevention at Harvard's T.H.Chan School of Public Health.That point is illustrated in a large study published Wednesday in the New England Journal of Medicine, involving decisions about chemotherapy.


moreover from nytimes

Gene Tests Identify Breast Cancer Patients Who Can Skip Chemotherapy, Study Says

Gene Tests Identify Breast Cancer Patients Who Can Skip Chemotherapy, Study Says

Dr. Kathryn J. Ruddy, a breast cancer specialist at the Mayo Clinic in Rochester, Minn., who was not part of the research, said in an email that the study was important because "it will help more patients avoid the toxicities of chemotherapy (potentially including permanent nerve damage, heart failure and leukemia)."The risks from certain types of chemo increase with the patient's age.The risk of leukemia is about 0.5 percent to 1 percent, and the heart risk can reach 4 percent or 5 percent in older women, Dr. Freedman said.The results of the study will be of most use for cases that have fallen into a gray zone, when the disease is in an early stage but has some anatomical features that suggest it may be aggressive.But the genomic test says it is low risk.